Optimo Medical Receives CE Mark for Optimeyes Surgical Planning Tool

Switzerland-based Optimo Medical AG announced that it has received CE Mark for Optimeyes as a Class 2b medical device.

The Optimeyes software predicts in a patient-specific way the influence of physical interventions in the cornea, allowing it to simulate and evaluate treatment results in the planning phase. Optimeyes is the world’s first patient-specific eye surgery planning tool able to optimize surgical parameters for the individual cornea, according to Optimo Medical.

Due to the modular software architecture, the Optimeyes simulation framework can also be integrated into diagnostic or therapeutic devices, such as anterior segment tomographers or femtosecond laser systems. The Optimeyes technology is developed as a medical device, according to ISO13485 standards, following IEC62304 processes.

Device manufacturers that incorporate Optimeyes into their system can provide simple surgery planning features to their customers. In addition, they can make money through the pay-per-use fees, thus generating a continuous revenue-stream, according to the Optimo Medical.